NT5E and breast carcinoma: As illustrated in Figure 5G and Supplemental Figure 10E, ST80 significantly reduced CD73 protein levels starting from 50 nM while Z22 reduced CD73 protein levels starting from 500 nM in MDA-MB231 and MDA-MB468 breast cancer cells.